| Sole Care Mobile Podiatry, Pllc | |
|
16427 N Scottsdale Rd Ste 434, Scottsdale, AZ 85254-7103 | |
| (480) 247-6494 | |
| (480) 247-6643 |
| Full Name | Sole Care Mobile Podiatry, Pllc |
|---|---|
| Type | Facility |
| Speciality | Clinic/center - Podiatric |
| Location | 16427 N Scottsdale Rd Ste 434, Scottsdale, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225588783 | NPI | - | NPPES |
| 219991 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Secondary |
| 261QP1100X | Clinic/center - Podiatric | 0829 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sole Care Mobile Podiatry, Pllc 11475 E Helm Dr, Scottsdale, AZ 85255-1887 Ph: (480) 247-6494 | Sole Care Mobile Podiatry, Pllc 16427 N Scottsdale Rd Ste 434, Scottsdale, AZ 85254-7103 Ph: (480) 247-6494 |
News Archive
Medical Air Technology (MAT) recently completed a project at the prestigious Liverpool School of Tropical Medicine (LSTM), increasing laboratory capacity to accommodate a new machine for counting and profiling cells. Founded in 1898, LSTM is the oldest School in Tropical Medicine in the world, and recognised globally for its groundbreaking research into infectious, debilitating and disabling diseases.
Dr. John Patton, co-founder and chief scientific officer for Nektar reported that Pfizer and The Sanofi-Aventis Group have announced that the FDA has accepted for filing a new drug application for Exubera (inhaled human insulin powder).
Encouraging results in a small study, with a new experimental treatment, promises help for certain diabetics to retain some ability to make their own insulin.
A national study from the University of New Hampshire shows children who witness the abuse of a brother or sister by a parent can be just as traumatized as those witnessing violence by a parent against another parent.
Essilor International has announced it is taking a 50% stake in Wanxin Optical, one of China's leading manufacturers of ophthalmic lenses, as part of a joint venture agreement.
› Verified 9 days ago